Discontinuation of Construction Work at MGC Specialty Chemicals Netherlands B.V.
February 20, 2026
Company name: Mitsubishi Gas Chemical Company, Inc.
Representative: Yoshinori Isahaya, Representative Director & President
Securities code: 4182 (The Prime Market of the Tokyo Stock Exchange)
Contact: Satoshi Takizawa, Division Director, CSR & IR Division
TEL: +81-3-3283-5041
Discontinuation of Construction Work at MGC Specialty Chemicals Netherlands B.V.
Mitsubishi Gas Chemical Company, Inc. (MGC) announced that it has decided at its Board of Directors meeting held on February 20, 2026 to discontinue construction work that had been implemented at MGC Specialty Chemicals Netherlands B.V. (hereinafter “MSCN”), a consolidated subsidiary in the Netherlands, to establish a meta-xylenediamine (MXDA) production facility. Details follow.
1. Reason for discontinuation
As announced in its press release dated September 17, 2025, MSCN decided to temporarily suspend construction work of this MXDA production facility due to construction schedule delays, a significant increase in construction costs, intensifying market competition, and other changes in the business environment. Following this decision, MGC assessed the recoverable value of MSCN’s noncurrent assts and thus recorded impairment losses associated with these noncurrent assets. These were publicly disclosed on November 10, 2025 and February 10, 2026 in conjunction with the financial results announcements for the first half and first nine months, respectively, of the fiscal year ending March 31, 2026.
Since then, MGC has considered a variety of options, including resuming construction work and partnering with an external company. However, MGC has concluded that the production and sale of MXDA would not allow MSCN to secure sufficient profit even if the facility in question were to be completed. Thus, as of today, MGC decided to discontinue said construction work. Looking ahead, MGC intends to launch procedures toward the shutdown of the facility, including the removal of its equipment, which the Company aims to finish by the end of 2029.
2. Overview of MSCN
| (1) Company name | MGC Specialty Chemicals Netherlands B.V. |
| (2) Location | Theemsweg 5, 3197 KM Botlek Rotterdam, Kingdom of the Netherlands |
| (3) Representative | Masatoshi Sato, Managing Director |
| (4) Establishment | January 2021 |
| (5) Business operations | Manufacture and sale of MXDA |
| (6) Initial scheduled production start | July 2024 |
| (7) Production capacity | 25,000 MTA |
| (8) Capital | 20 million euro |
| (9) Ownership ratio | MGC 100% |
| (10) Relationship between the listed company and the company concerned | Specified subsidiary |
3. Outlook
The MGC Group is currently examining the impact of this decision and other implications on its consolidated and non-consolidated operating results for the fiscal year ending March 31, 2026. The Company will promptly make an announcement should any matters requiring disclosure arise. In addition, the discontinuation of construction work is expected to cause MGC to record various relevant costs, such as those arising from the removal of equipment and contract-related procedures.
END